Nantahala Capital Management, LLC 13D and 13G filings for Quince Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:38 pm Purchase | 2026-03-31 | 13G | QUINCE THERAPEUTICS, INC QNCX | Nantahala Capital Management, LLC | 4,528,302 7.520% | 3,966,260 (+705.69%) | Filing |
| 2025-11-14 4:32 pm Purchase | 2025-09-30 | 13G | QUINCE THERAPEUTICS, INC QNCX | Nantahala Capital Management, LLC | 562,042 9.990% | 85,456 (+17.93%) | Filing |
| 2025-08-14 4:33 pm Purchase | 2025-06-30 | 13G | QUINCE THERAPEUTICS, INC QNCX | Nantahala Capital Management, LLC | 476,586 9.990% | 476,586 (New Position) | Filing |